Chuck Royce's position in United Therapeutics is currently worth $3.01 Million. That's 0.03% of their equity portfolio (494th largest holding). Chuck Royce started to build up the position in United Therapeutics in Q3 2020 and continued to invest until Q1 2021. Since then they sold 214 Thousand shares. The stake costed the investor $1.38 Million, netting the investor a gain of 119% so far.